PCN39 EXPLORATORY COST EFFECTIVENESS ANALYSIS OF BEVACIZUMAB IN ADDITION TO FOLFOX-4 IN THE ADJUVANT TREATMENT OF STAGE III COLON CANCER: A UK PERSPECTIVE
2005 ◽
Vol 3
(2)
◽
pp. 182-183
2005 ◽
Vol 23
(16_suppl)
◽
pp. 3532-3532
◽
2015 ◽
Vol 22
(5)
◽
pp. 311-319
◽
2006 ◽
Vol 95
(9)
◽
pp. 1195-1201
◽
Keyword(s):
2009 ◽
Vol 27
(7)
◽
pp. 597-608
◽
2021 ◽
pp. cebp.0078.2021